304930
Innovative Method for Identifying and Re-Engaging Lost HIV Clinic Patients: The Navigation Program
Description: Eligible lost clinic patients included HIV-infected adults with either: a) no reported VL/CD4 measures in previous 12mo per HIV surveillance; b) no reported VL/CD4 in 7-12mo and most recent VL>200copies/ml; c) newly- diagnosed and not linked to care within 3mo; and d) recent incarceration with no regular provider.
Lessons Learned: Navigation Program pilot data for 499 lost clinic patients at four HIV clinics has determined that 43% were ineligible(in-care elsewhere, deceased, not LAC residents); 43% were unavailable or had invalid contact information and 12% were located and enrolled(n=47). The majority were Latino(68%), male(72%), and uninsured(51%).The most useful contact information came from HIV surveillance(39%) and clinic medical records(36%). An average of 7 appointments over 90 days was needed to link patients to care. A total of 98% of participants were linked to care.
Recommendations: HIV surveillance and clinic medical records provided the most useful contact information and the modified ARTAS intervention was effective at linking persons to care.
Learning Areas:
Planning of health education strategies, interventions, and programsPublic health or related research
Learning Objectives:
Evaluate the effectiveness of using multiple surveillance sources for identifying HIV infected persons who have fallen out of care.
Compare different intervention strategies designed to re-engage HIV infected person who have fallen out of care.
Keyword(s): HIV/AIDS, HIV Interventions
Qualified on the content I am responsible for because: I have multiple years of experience in the fields of HIV research and program evaluation. I have also performed program management for multiple federally funded research projects related to HIV prevention and health care delivery.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.